Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma
NCT00093119
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Metastases
Interventions
DRUG:
ABI-007
Sponsor
Celgene